Magnetic nanoparticles leap from lab bench to breast cancer clinical trials
Dale Huber has been working on the challenge of making iron-based nanoparticles the exact same size for 15 years. Now, the Sandia materials chemist and his long-term collaborators at Imagion Biosystems will use these magnetic nanoparticles for their first breast cancer clinical trial later this year.